Key2Compliance is expanding outside Sweden’s borders for the first time.

Recruitment has already started for the Danish office in Copenhagen, states the company in a press release.

”We already have a number of Danish customers and have completed numerous courses and training there. This was a natural step,” says CEO Jan Hellqvist.

Continue the growth

Over the past two years, the company has gone from three to six business areas and has increased its workforce from 16 to just over 50 employed consultants. Symbioteq AB acquired Key2Compliance AB a few years ago and chose to change the name of the operating company to Key2Compliance AB for the entire business. It has offices in Stockholm, Gothenburg and Lund.

”To continue this growth, it was necessary to take the step to Denmark and establish an office in Copenhagen. We have now for the first time registered a company outside Sweden’s borders, which feels extremely exciting. But this is just the beginning of our international journey,” says Hellqvist.

Country Manager

Susanne Søeborg has been hired as Country Manager with responsibility for the Danish business development. She most recently came from a position as Application Specialist at Radiometer Medical. She has extensive experience from both Medtech, in vitro diagnostics, and training and education.

”I know that Key2Compliance is an extremely serious and driven company and I’m convinced that the establishment in Copenhagen will be successful. Being part of this journey in Denmark will be challenging and fun,” says Susanne Søeborg.

In addition, Per H Damgaard, who has been collaborating with Key2Compliance for several years, has been tied closer to the business.

Read more: Are you ready for MDR?

Danish consultants within Medtech and Pharma

The plan is to continue recruiting Danish consultants within Medtech and Pharma, with a focus on Quality Assurance and Regulatory Affairs in a first step, and to use existing Swedish consultants. The office is located in the Life Science cluster Symbion in northern Copenhagen.

”The future is bright, both for consulting services and training within Medtech and Pharma. There are new regulations to consider and a great need for new, innovative products. In addition, there are a growing number of startups in both medical technology and pharma that are in the pre-clinical or early clinical stage,” says Hellqvist.

Photo: iStock